View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab Deruxtecan 5.4, Breast Cancer
Protocol-ID: 1634 V1.1 (Mini), TRASDE5.4, Breast CaIndication(s)
- Breast Cancer; ICD-10 C50.-
HER2+ ● HER2-low
HER2-low & HR+ ● HER2-ultralow & HR+
Links
- ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.08.2025